CEO Brent Lucas of Envoy Medical (NASDAQ: COCH), an innovative hearing health technology company and sole US-domiciled cochlear implant company joins the WTR Healthcare Happenings podcast to talk about hearing loss, the third most chronic physical condition prevalent in the US, and how Envoy's innovative device technology can disrupt the hearing solutions market that has long lacked transformative advancements. Lucas discusses Envoy's two fully implantable hearing solution products, one in the market (Esteem), the only FDA approved middle ear implant for moderate to severe hearing loss, and the other (Acclaim), a cochlear implant targeting severe to profound hearing loss which is currently in the advanced stages of clinical development (Acclaim), the competitive landscape and the commercial opportunities.